Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Construction in Progress (2022 - 2024)

Korro Bio (KRRO) has disclosed Construction in Progress for 3 consecutive years, with $18.3 million as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Construction in Progress changed N/A year-over-year to $18.3 million, compared with a TTM value of $18.3 million through Jun 2024, changed N/A, and an annual FY2023 reading of $8.2 million, up 310.0% over the prior year.
  • Construction in Progress was $18.3 million for Q2 2024 at Korro Bio, up from $13.4 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $18.3 million in Q2 2024 and bottomed at $2.0 million in Q4 2022.
  • Average Construction in Progress over 3 years is $10.5 million, with a median of $10.8 million recorded in 2023.
  • Peak annual rise in Construction in Progress hit 310.0% in 2023, while the deepest fall reached 310.0% in 2023.
  • Year by year, Construction in Progress stood at $2.0 million in 2022, then surged by 310.0% to $8.2 million in 2023, then soared by 123.17% to $18.3 million in 2024.
  • Business Quant data shows Construction in Progress for KRRO at $18.3 million in Q2 2024, $13.4 million in Q1 2024, and $8.2 million in Q4 2023.